Thursday, June 11

EndPoints

Flagship biotech Valo Health ends 2024 with mid-stage fail

Max BayerDecember 31, 2024

EndPoints

Pfizer ends work on Sangamo’s hemophilia gene therapy, crushing biotech’s hopes

Kyle LaHucikDecember 31, 2024

EndPoints

Despite mixed data in Alzheimer’s agitation, Axsome will still seek FDA approval

Max GelmanDecember 30, 2024

Browsing: EndPoints

EndPoints

Novartis ends Phase 1 radiopharma trial; Solve Therapeutics pursues $75M round

ENDPOINTSDecember 27, 2024

Novartis ends a radiopharma trial with PeptiDream: The Swiss drug giant terminated a Phase 1 trial of Lu-FF58 in patients…

EndPoints

BioNTech settles with NIH, UPenn in Covid vaccine disputes and will pay royalties

Kyle LaHucikDecember 27, 2024

BioNTech has entered into settlement agreements with the NIH and the University of Pennsylvania, marking a key turning point in…

EndPoints

WuXi AppTec sells cell and gene therapy business to investor

Max BayerDecember 26, 2024

WuXi AppTec will sell its Advanced Technologies unit to the US private equity firm Altaris for an undisclosed amount, a…

EndPoints

Federal appeals court says Teva must delist Orange Book inhaler patents

Nicole DeFeudisDecember 23, 2024

The Federal Trade Commission is praising an appeals court decision calling for Teva to delist five inhaler patents from the…

EndPoints

CMS explains what went into its first round of drug price negotiations

Zachary BrennanDecember 23, 2024

The Centers for Medicare and Medicaid Services on Friday released detailed but heavily redacted explanations of how it determined new…

EndPoints

Drugmakers sue government over 340B discounts to STD clinics

Max BayerDecember 23, 2024

Amgen, Eli Lilly and UCB sued the federal government, claiming that several STD clinics getting drug discounts under the federal…

EndPoints

Viatris’ India-based manufacturing site blocked from shipping 11 generic drugs to US

Zachary BrennanDecember 23, 2024

Generic drug firm Viatris announced Monday that one of its India-based manufacturing facilities has been placed on import alert by…

EndPoints

Deerfield to buy Singular Genomics, beating out rival

Jared WhitlockDecember 23, 2024

An affiliate of Deerfield Management Company will acquire Singular Genomics Systems, ending a months-long competition between two suitors that bid…

EndPoints

Sumitomo’s overactive bladder drug adds another indication

Max BayerDecember 23, 2024

Sumitomo Pharma’s oral treatment for overactive bladder symptoms won an expanded label from the FDA, and is now approved to…

EndPoints

Next pipeline drugs for weight loss after CagriSema disappointment

Elizabeth CairnsDecember 23, 2024

The weaker-than-hoped weight loss seen with Novo Nordisk’s CagriSema knocked the company’s shares badly on Friday. The Danish group spearheaded…